14.03.2017 • NewsElaine BurridgewaterKemira

Kemira Merges Business Units

(c) Kemira
(c) Kemira

Finnish chemicals company Kemira is merging its Municipal & Industrial and Oil & Mining segments into a new business unit called Industry & Water in order to improve efficiency and enhance its customer service.

The organization will consist of two segments, Industry & Water and Pulp & Paper, with the new structure targeted to go into effect on Jun. 1. The proposed restructuring is expected to deliver annual savings of €15-20 million with a full run rate by the end of 2017.

“By merging two segments into one, we create a bigger and stronger segment with around €910 million in revenue. Oil & gas and mining remain our key customer industries and we further strengthen our position in water treatment,” said Kemira's president & CEO Jari Rosendal, adding that the move is an additional important step toward achieving its strategic target to grow above the market.

As a result of the planned changes, president of the Oil & Mining segment, Tarjei Johansen, will leave the company this month. Antti Salminen, currently president of the Municipal & Industrial segment, will act as the interim president of the Oil & Mining business and region Americas from Mar. 9 until the merger is completed.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.